Lucid Group Communications is a specialist provider of strategic medical communications services to global pharmaceutical companies.  Logo

Lucid Group Communications is a specialist provider of strategic medical communications services to global pharmaceutical companies.

Lucid Group provides medical education, medical communication, strategic consultancy and digital services to clients to drive better disease and patient management. 

The company has offices in London, Beaconsfield and NYC and employs over 100 people. With growth exceeding 30 per cent for the previous two years, it has built strong, sustainable partnerships with many of the world’s leading Pharma companies. 

In June 2017 LDC completed an £11million minority investment in Lucid Group Communications.

Founded in 2007 by Jan Steele and Dennis O’Brien, who will both continue to lead the business, the investment will enable Lucid to continue to build infrastructure to support its rapid growth, ensuring that its services and offerings remain of the highest quality. It will also enable stronger market presence in the US, where the business launched in 2016.

In addition, the investment will support Lucid to build its digital and creative capability, to broaden support for clients. 

 

We felt the time was right to bring on board a strategic partner, and in LDC we have an experienced investor with a strong track record in the healthcare sector. From the outset, they have had a flexible approach to the investment, structuring the deal on terms that worked for us. Dennis O'Brien, CEO, Lucid